Journal Specialty Index  

Rheumatology & Allergy

Topic	Issue
Rheumatoid Arthritis Treatment: From Biologics to Janus Kinase Inhibitors	AUGUST 2025 ‧ VOL. 17 ‧ NO. 7
Cancer Screening in Adult Patients With Idiopathic Inflammatory Myopathies	AUGUST 2025 ‧ VOL. 17 ‧ NO. 7
Eosinophilic Granulomatosis With Polyangiitis: What Is New and How to Treat?	AUGUST 2025 ‧ VOL. 17 ‧ NO. 7
Giant Cell Arteritis: An Updated Review for Clinicians	SEPTEMBER 2024 ‧ VOL. 16 ‧ NO. 9
Early Identification of Systemic Sclerosis (Scleroderma) – Does It Matter?	SEPTEMBER 2024 ‧ VOL. 16 ‧ NO. 9
Psoriatic Arthritis: Latest Update on Treatment	SEPTEMBER 2024 ‧ VOL. 16 ‧ NO. 9
Connective Tissue Disease-Associated Interstitial Lung Disease	AUGUST 2023 ‧ VOL. 5 ‧ NO. 6
Updates on Idiopathic Inflammatory Myopathies	AUGUST 2023 ‧ VOL. 5 ‧ NO. 6
Cardiovascular Effects of Glucocorticoids for Rheumatoid Arthritis: Friend or Foe?	AUGUST 2023 ‧ VOL. 5 ‧ NO. 6
Axial Spondyloarthritis: Diagnostic Approach and Novel Treatments	AUGUST 2023 ‧ VOL. 5 ‧ NO. 6
Early Food Introduction as a Prevention Strategy for Childhood Food Allergies: Principles and Practice	MARCH 2023 ‧ VOL. 5 ‧ NO. 1
Prescribing Antirheumatic Medications in Pregnancy and Lactation	AUGUST 2022 ‧ VOL. 14 ‧ NO. 7
Role of Musculoskeletal Ultrasound in Rheumatology Clinics and the Road Ahead	AUGUST 2022 ‧ VOL. 14 ‧ NO. 7
Glucocorticoid-Induced Osteoporosis: What You Need to Know	AUGUST 2022 ‧ VOL. 14 ‧ NO. 7
Risks of Infection in Spondyloarthritis	AUGUST 2022 ‧ VOL. 14 ‧ NO. 7
Clinical Implications of Myositis-Specific Autoantibodies	AUGUST 2022 ‧ VOL. 14 ‧ NO. 7
Real-World Evidence With IL-17 and IL-23 Inhibitors in Psoriasis Treatment	APRIL 2022 ‧ VOL. 14 ‧ NO. 3
Atopic Dermatitis Overview and Updates on the Use of Biologics in Its Treatment	APRIL 2022 ‧ VOL. 14 ‧ NO. 3
Desensitisation Therapies for Asthma	MAY 2021 ‧ VOL. 13 ‧ NO. 5
Update on the Treatment of Psoriatic Arthritis. What's New in 2021?	MARCH 2021 ‧ VOL. 13 ‧ NO. 3
Raynaud's Phenomenon - The Primary-Care Perspective	MARCH 2021 ‧ VOL. 13 ‧ NO. 3
COVID-19 Vaccines and Patients With Autoimmune Rheumatic Disease: What Do We Know So Far?	MARCH 2021 ‧ VOL. 13 ‧ NO. 3
Monogenic Disorders of Autoimmunity: Targeted Molecular Diagnostics and Treatment in the Era of Precision Medicine	MARCH 2021 ‧ VOL. 13 ‧ NO. 3
The Role of Dermatologists in Early Diagnosis and Management of Psoriatic Arthritis in Patients With Psoriasis	OCTOBER 2020 ‧ VOL. 12 ‧ NO. 9
Biologic and Targeted Therapies for Rheumatoid Arthritis	MARCH 2020 ‧ VOL. 12 ‧ NO. 3
The Management of Hyperuricaemia in Chronic Kidney Disease and Cardiovascular Disorders	MARCH 2020 ‧ VOL. 12 ‧ NO. 3
Leukocytoclastic Vasculitis	MARCH 2020 ‧ VOL. 12 ‧ NO. 3
Vaccinations in Rheumatic Disease Patients	MARCH 2020 ‧ VOL. 12 ‧ NO. 3
Interleukin-23: A Newer Target for Treating Patients with Moderate-to-Severe Psoriasis	DECEMBER 2019 ‧ VOL. 11 ‧ NO. 9
New Tricks for the Management of Mild Asthma	MAY 2019 ‧ VOL. 11 ‧ NO. 4
The Management of Psoriatic Arthritis	MARCH 2019 ‧ VOL. 11 ‧ NO. 2
Inflammatory Myopathies - a Practical Diagnostic Approach	MARCH 2019 ‧ VOL. 11 ‧ NO. 2
Immune-related Adverse Event of Cancer Immunotherapy	MARCH 2019 ‧ VOL. 11 ‧ NO. 2
Updates on the Use of Biologics in Patients with Psoriasis	JANUARY 2019 ‧ VOL. 11 ‧ NO. 1
Disruptions in Medicine: What are the Impacts for Hong Kong?	NOVEMBER 2018 ‧ VOL. 10 ‧ NO. 7
Updates on Allergic Diseases: Diagnostic Workup and Pearls on Management	SEPTEMBER 2018 ‧ VOL. 10 ‧ NO. 6
Early Diagnosis and Management of Spondyloarthritis	MARCH 2018 ‧ VOL. 10 ‧ NO. 2
Diagnosis and Management of Sjogren's Syndrome	MARCH 2018 ‧ VOL. 10 ‧ NO. 2
The Use of Glucocorticoids in Rheumatic Diseases	MARCH 2018 ‧ VOL. 10 ‧ NO. 2
Behcet's Disease	MARCH 2018 ‧ VOL. 10 ‧ NO. 2
Update on Diagnosis and Management of Psoriatic Arthritis	NOVEMBER 2017 ‧ VOL. 9 ‧ NO. 7
Comorbidities of Gout	APRIL 2017 ‧ VOL. 9 ‧ NO. 3
Updates on the Management of Rheumatoid Arthritis	APRIL 2017 ‧ VOL. 9 ‧ NO. 3
Update on the Management of Vasculitides	APRIL 2017 ‧ VOL. 9 ‧ NO. 3
Current Understanding of Spondyloarthritis	APRIL 2017 ‧ VOL. 9 ‧ NO. 3
Spondyloarthritis: Early Diagnosis and Treatment with Biologics	NOVEMBER 2016 ‧ VOL. 8 ‧ NO. 7
Overview of IgG4-related Disease: A Novel Entity	JULY 2016 ‧ VOL. 8 ‧ NO. 5
Gout: What is the Treatment Target and How to Achieve the Target?	FEBRUARY 2016 ‧ VOL. 8 ‧ NO. 2
Glucocorticoid-induced Osteoporosis	FEBRUARY 2016 ‧ VOL. 8 ‧ NO. 2
Role of Musculoskeletal Ultrasound in Diagnosing Arthritis: Insight from New Classification Criteria	FEBRUARY 2016 ‧ VOL. 8 ‧ NO. 2
The Era of Biological Therapies in the Management of Psoriasis	DECEMBER 2015 ‧ VOL. 7 ‧ NO. 7
Rheumatoid Arthritis and Related Disorders	NOVEMBER 2015 ‧ VOL. 7 ‧ NO. 6
Update in the Classification Criteria for Systemic Lupus Erythematous	MARCH 2015 ‧ VOL. 7 ‧ NO. 2
Childhood Arthritis: A Review	MARCH 2015 ‧ VOL. 7 ‧ NO. 2
The 2010 Rheumatoid Arthritis Classification Criteria	MARCH 2015 ‧ VOL. 7 ‧ NO. 2
New Spondyloarthritis Classification Criteria and the Hong Kong Society of Rheumatology Back Pain Referral Guideline	MARCH 2015 ‧ VOL. 7 ‧ NO. 2
Biological Therapies in Rheumatic Diseases	JANUARY 2015 ‧ VOL. 7 ‧ NO. 1
Overview of Psoriasis for Clinicians	NOVEMBER 2014 ‧ VOL. 6 ‧ NO. 7
Glucocorticoid Use in Rheumatology: Mechanism of Action, Adverse Effects and Guidance on Monitoring	MARCH 2014 ‧ VOL. 6 ‧ NO. 2
Fibromyalgia	MARCH 2014 ‧ VOL. 6 ‧ NO. 2
Immunosuppresants in Systemic Lupus Erythematosus - Treatment Options and Potential Toxicity	MARCH 2014 ‧ VOL. 6 ‧ NO. 2
Risks and Benefits of Biologic Agents in Rheumatic Disease	MARCH 2014 ‧ VOL. 6 ‧ NO. 2
Selective COX-2 Inhibitors and Non-Selective NSAIDs: A Recap	MARCH 2014 ‧ VOL. 6 ‧ NO. 2
Update on Gout Management	DECEMBER 2013 ‧ VOL. 5 ‧ NO. 7
Cardiovascular Risk Factors, Morbidity and Mortality in Psoriasis	NOVEMBER 2013 ‧ VOL. 5 ‧ NO. 6
Update on Management of Gout and Hyperuricaemia	JANUARY 2013 ‧ VOL. 5 ‧ NO. 1
Update on Novel Therapies for Systemic Lupus Erythematosus	JANUARY 2013 ‧ VOL. 5 ‧ NO. 1
Update on Treatments in Spondyloarthritis	JANUARY 2013 ‧ VOL. 5 ‧ NO. 1
Treat-to-Target in Rheumatoid Arthritis	JANUARY 2013 ‧ VOL. 5 ‧ NO. 1
Updates on Systemic Lupus Erythematosus	DECEMBER 2012 ‧ VOL. 4 ‧ No. 7
Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): Clinical Update and Literature Review	NOVEMBER 2012 ‧ VOL. 4 ‧ NO. 6
Rheumatoid Arthritis: Advances in Therapeutics	MARCH 2012 ‧ VOL. 4 ‧ NO. 2
The Challenge and Essence of the Management of Psoriasis	MARCH 2012 ‧ VOL. 4 ‧ NO. 2
Cardiovascular Risk in Patients With Psoriatic Arthritis	JANUARY 2012 ‧ VOL. 4 ‧ NO. 1
Safety of Biologic Agents in Inflammatory Diseases	DECEMBER 2011 ‧ VOL. 3 ‧ NO. 7
Medical Treatment of Ankylosing Spondylitis	JULY 2010 ‧ VOL. 2 ‧ NO. 4
Era of Biologics: Therapeutic Strategies for Rheumatoid Arthritis	JULY 2009 ‧ VOL. 1 ‧ NO. 3